Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11880538rdf:typepubmed:Citationlld:pubmed
pubmed-article:11880538lifeskim:mentionsumls-concept:C1522021lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0524869lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C1336633lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0883208lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0015111lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:11880538lifeskim:mentionsumls-concept:C0439603lld:lifeskim
pubmed-article:11880538pubmed:issue2lld:pubmed
pubmed-article:11880538pubmed:dateCreated2002-3-6lld:pubmed
pubmed-article:11880538pubmed:abstractTextN-ethyl-N-nitrosourea (ENU) is a potent monofunctional ethylating agent that has been found to be mutagenic in a wide variety of organisms from viruses to mammalian germ cells. To elucidate the mutagenicity of ENU at the Tk(+/-) locus of mouse lymphoma cells and to confirm the ability of the mouse lymphoma assay (MLA) to detect both point mutations and large DNA alterations, Tk(+/-) L5178Y cells were exposed to different doses of ENU. Treatment of the cells with ENU resulted in a linear dose response with mutant frequencies of up to 16-fold over control. Evaluation of mutant clone size showed that 36% of the 100 microg/ml ENU-induced clones (66% in control) were small colony mutants and 64% (34% in control) were large colony mutants. DNA isolated from mutants in the control culture and the 100 microg/ml ENU treatment group was analyzed for loss of heterozygosity (LOH) using allele-specific PCR. The majority of the small colony mutants, both ENU-treated (97%) and spontaneous (91%), lost the Tk1b allele. The percentage of allele loss in ENU-induced large colony mutants was distinctly different from that of the control. Twenty-three percent of ENU-induced large colony mutants lost their Tk1b alleles, whereas 73% of the large colony mutants from the control culture lost the allele (P < 0.001). Overall, 50% of the Tk mutants from the 100 microg/ml ENU-treated cultures (86% in control) showed LOH. Our data indicate that ENU is a potent mutagen in mouse lymphoma cells and that 100 microg/ml ENU induces equal numbers of point mutations and chromosomal mutations. This study serves to verify that the MLA detects both point mutations and chromosomal mutations.lld:pubmed
pubmed-article:11880538pubmed:languageenglld:pubmed
pubmed-article:11880538pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11880538pubmed:citationSubsetIMlld:pubmed
pubmed-article:11880538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11880538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11880538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11880538pubmed:statusMEDLINElld:pubmed
pubmed-article:11880538pubmed:monthMarlld:pubmed
pubmed-article:11880538pubmed:issn0267-8357lld:pubmed
pubmed-article:11880538pubmed:authorpubmed-author:ChenTaoTlld:pubmed
pubmed-article:11880538pubmed:authorpubmed-author:Harrington-Br...lld:pubmed
pubmed-article:11880538pubmed:authorpubmed-author:MooreMartha...lld:pubmed
pubmed-article:11880538pubmed:issnTypePrintlld:pubmed
pubmed-article:11880538pubmed:volume17lld:pubmed
pubmed-article:11880538pubmed:ownerNLMlld:pubmed
pubmed-article:11880538pubmed:authorsCompleteYlld:pubmed
pubmed-article:11880538pubmed:pagination105-9lld:pubmed
pubmed-article:11880538pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:meshHeadingpubmed-meshheading:11880538...lld:pubmed
pubmed-article:11880538pubmed:year2002lld:pubmed
pubmed-article:11880538pubmed:articleTitleMutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.lld:pubmed
pubmed-article:11880538pubmed:affiliationDivision of Genetic and Reproductive Toxicology, National Center for Toxicological Research, FDA, Jefferson, AR 72079, USA. tchen@nctr.fda.govlld:pubmed
pubmed-article:11880538pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11880538pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11880538pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:21877entrezgene:pubmedpubmed-article:11880538lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11880538lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11880538lld:pubmed